Literature DB >> 16941107

Molecular pathogenesis of SLE.

Toshikazu Shirai1, Sachiko Hirose.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16941107     DOI： 10.1007/s00281-006-0032-5

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  1 in total

Review 1.  Genome screening for susceptibility loci in systemic lupus erythematosus.

Authors:  Toshikazu Shirai; Hiroyuki Nishimura; Yi Jiang; Sachiko Hirose
Journal:  Am J Pharmacogenomics       Date:  2002
  1 in total
  3 in total

1.  High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus.

Authors:  Deena A Abdulahad; Johanna Westra; Johannes Bijzet; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Journal:  Arthritis Res Ther       Date:  2011-05-06       Impact factor: 5.156

2.  Autoantibodies to NR2A Peptide of the Glutamate/NMDA Receptor in Patients with Seizure Disorders in Neuropsychiatric Systemic Lupus Erythematosus.

Authors:  Yan Yang; Chao Yuan; Shu-Qun Shen; Xue-Er Wang; Qing-Hua Mei; Wen-Qing Jiang; Qin Huang
Journal:  Mediators Inflamm       Date:  2017-01-05       Impact factor: 4.711

3.  Bim suppresses the development of SLE by limiting myeloid inflammatory responses.

Authors:  FuNien Tsai; Philip J Homan; Hemant Agrawal; Alexander V Misharin; Hiam Abdala-Valencia; G Kenneth Haines; Salina Dominguez; Christina L Bloomfield; Rana Saber; Anthony Chang; Chandra Mohan; Jack Hutcheson; Anne Davidson; G R Scott Budinger; Philippe Bouillet; Andrea Dorfleutner; Christian Stehlik; Deborah R Winter; Carla M Cuda; Harris Perlman
Journal:  J Exp Med       Date:  2017-11-07       Impact factor: 14.307
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.